Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 41% ± 15% | |
lung | 15 studies | 32% ± 11% | |
intestine | 11 studies | 27% ± 11% | |
kidney | 7 studies | 31% ± 5% | |
brain | 6 studies | 23% ± 3% | |
eye | 5 studies | 29% ± 10% | |
lymph node | 5 studies | 33% ± 6% | |
pancreas | 4 studies | 29% ± 2% | |
placenta | 4 studies | 26% ± 6% | |
bone marrow | 4 studies | 27% ± 8% | |
uterus | 4 studies | 43% ± 14% | |
breast | 4 studies | 27% ± 5% | |
liver | 4 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3183.90 | 1445 / 1445 | 100% | 38.07 | 183 / 183 |
kidney | 100% | 3120.99 | 89 / 89 | 100% | 46.37 | 901 / 901 |
ovary | 100% | 5071.13 | 180 / 180 | 100% | 44.66 | 430 / 430 |
prostate | 100% | 3087.76 | 245 / 245 | 100% | 51.45 | 502 / 502 |
thymus | 100% | 3631.69 | 653 / 653 | 100% | 88.50 | 605 / 605 |
uterus | 100% | 3906.69 | 170 / 170 | 100% | 54.87 | 459 / 459 |
brain | 100% | 1894.89 | 2638 / 2642 | 100% | 40.99 | 705 / 705 |
lung | 100% | 2830.35 | 577 / 578 | 100% | 41.95 | 1154 / 1155 |
breast | 100% | 4094.48 | 459 / 459 | 100% | 51.13 | 1115 / 1118 |
bladder | 100% | 3679.33 | 21 / 21 | 100% | 47.92 | 502 / 504 |
stomach | 100% | 2849.78 | 359 / 359 | 99% | 41.07 | 284 / 286 |
intestine | 100% | 3786.31 | 966 / 966 | 99% | 44.40 | 523 / 527 |
adrenal gland | 100% | 3196.79 | 258 / 258 | 99% | 36.18 | 228 / 230 |
liver | 99% | 1227.92 | 224 / 226 | 100% | 28.69 | 406 / 406 |
pancreas | 99% | 1960.93 | 324 / 328 | 100% | 49.05 | 178 / 178 |
skin | 100% | 3299.19 | 1809 / 1809 | 99% | 46.96 | 466 / 472 |
adipose | 100% | 3985.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4543.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 63.47 | 29 / 29 |
muscle | 100% | 3042.91 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3207.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.77 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 38.86 | 79 / 80 |
heart | 98% | 1888.24 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2484.70 | 895 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0048568 | Biological process | embryonic organ development |
GO_0007369 | Biological process | gastrulation |
GO_0001701 | Biological process | in utero embryonic development |
GO_0016607 | Cellular component | nuclear speck |
GO_0071014 | Cellular component | post-mRNA release spliceosomal complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0000974 | Cellular component | Prp19 complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SYF2 |
Protein name | Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29) |
Synonyms | CBPIN GCIPIP |
Description | FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome . . |
Accessions | O95926 ENST00000354361.3 [O95926-2] ENST00000236273.9 [O95926-1] |